New patent for Exeltis Usa drug SLYND

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SLYND
Annual Drug Patent Expirations for SLYND

Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug.

SLYND drug price trends.

This drug has forty-eight patent family members in twenty-eight countries.

The generic ingredient in SLYND is drospirenone. Additional details are available on the drospirenone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top